PRELUDE CAPITAL MANAGEMENT, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 51 filers reported holding LEAP THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$152,00072,7270.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sio Capital Management, LLC 476,223$533,0000.13%
683 Capital Management, LLC 150,142$168,0000.02%
Alyeska Investment Group, L.P. 514,285$576,0000.01%
Baker Brothers Advisors 978,454$1,096,0000.01%
Quilter Plc 50,000$56,0000.00%
Schonfeld Strategic Advisors LLC 80,319$90,0000.00%
FMR LLC 660,800$740,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lionsbridge Wealth Management LLC 181$00.00%
GEODE CAPITAL MANAGEMENT, LLC 328,986$368,0000.00%
View complete list of LEAP THERAPEUTICS INC shareholders